PRICE T ROWE ASSOCIATES INC /MD/ - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$11,941,000
-86.8%
633,121
-91.8%
0.00%
-84.6%
Q2 2019$90,560,000
-27.1%
7,694,119
-15.5%
0.01%
-27.8%
Q1 2019$124,291,000
+57.2%
9,105,567
+18.1%
0.02%
+38.5%
Q4 2018$79,049,000
-34.3%
7,712,078
+6.8%
0.01%
-27.8%
Q3 2018$120,256,000
+308.6%
7,222,584
+287.7%
0.02%
+350.0%
Q2 2018$29,431,000
+113.7%
1,862,713
+71.8%
0.00%
+100.0%
Q1 2018$13,771,000
+11.4%
1,084,303
+0.5%
0.00%0.0%
Q4 2017$12,358,000
+5.8%
1,079,279
+13.2%
0.00%0.0%
Q3 2017$11,678,000
+3.5%
953,279
-3.3%
0.00%0.0%
Q2 2017$11,284,000
+29.7%
985,529
+135.7%
0.00%0.0%
Q1 2017$8,697,000
-4.0%
418,129
-4.0%
0.00%0.0%
Q4 2016$9,061,000
-4.8%
435,629
+50.0%
0.00%0.0%
Q3 2016$9,518,000
+334.0%
290,446
+224.3%
0.00%
Q1 2016$2,193,000
-45.9%
89,555
-27.0%
0.00%
-100.0%
Q4 2015$4,053,000
+0.9%
122,698
+0.0%
0.00%0.0%
Q3 2015$4,018,000
+76.4%
122,638
+185.2%
0.00%
Q2 2015$2,278,00043,0000.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders